Poslední zkoušky

EudraCT Number: 2004-001331-36 Sponsor Protocol Number: EORTC 08021 - ILCP Start Date: 2005-02-17
Sponsor Name: IST. DI RICERCHE FARMACOLOG. M. NEGRI
Full Title: A randomized phase III study of follow-up with or without Gefitinib (IressaTM) following chemotherapy in patients with advanced non-small cell lung cancer.
Medical condition: Non small cell lung cancer, advanced.
Disease: Version SOC Term Classification Code Term Level
6.1 10061873 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2004-004149-16 Sponsor Protocol Number: H3E-ES-S085 Start Date: 2005-02-16
Sponsor Name: Lilly S.A.
Full Title: Phase 1/2 Study of Biweekly ALIMTA plus Cisplatin in patients with Locally Advanced, non-Resectable or Metastatic Urothelial Cancer
Medical condition: Locally Advanced, non-Resectable or Metastatic Urothelial Cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2004-002228-17 Sponsor Protocol Number: 2-2004 Start Date: 2005-02-16
Sponsor Name: Danderyds Sjukhus
Full Title: Blödningsmönster och klinisk uppföljning av kvinnor som genomgått medicinsk abort och som har fått Implanon insatt i samband med aborten eller vid den första menstruationen efter aborten.
Medical condition: Blödningsmönster och klinisk uppföljning av kvinnor som genomgått medicinsk abort och har fått Implanon insatt i samband med aborten eller vid den första menstruationen efter aborten.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-004592-11 Sponsor Protocol Number: IGN101/2-02 Start Date: 2005-02-16
Sponsor Name: IGENEON
Full Title: Vaccination with IGN101 in patients with non-small-cell-lung-cancer (NSCLC)
Medical condition: Non-small-cell-lung-cancer stages IB, II A/B, III A
Disease: Version SOC Term Classification Code Term Level
6.1 10061873 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2004-002795-42 Sponsor Protocol Number: C04-002 Start Date: 2005-02-16
Sponsor Name: ALEXION PHARMACEUTICALS INCORPORATED
Full Title: Safety in Hemolytic PNH Patients Treated with Eculizumab: A Multi-center Open-label Research Design Study
Medical condition: paroxysmal nocturnal hemoglobinuria
Disease: Version SOC Term Classification Code Term Level
7.0 10034042 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) IE (Completed) DE (Completed) GB (Completed) IT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-000020-32 Sponsor Protocol Number: CV131-176 Start Date: 2005-02-16
Sponsor Name: Bristol Myers Squibb International Corporation
Full Title: The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension
Medical condition: Severe Hypertension
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results
EudraCT Number: 2004-001491-39 Sponsor Protocol Number: 03-0-192 Start Date: 2005-02-16
Sponsor Name: Astellas Pharma US, Inc.
Full Title: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE STUDY OF MICAFUNGIN (FK463) VERSUS CASPOFUNGIN AS ANTIFUNGAL TREATMENT IN PATIENTS WITH INVASIVE CANDIDIASIS OR CANDIDEMIA
Medical condition: Invasive candidiasis or candidemia
Disease: Version SOC Term Classification Code Term Level
7.0 10042938 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed) GB (Completed) BE (Completed) AT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-001054-84 Sponsor Protocol Number: 2004/W/GI/02 Start Date: 2005-02-16
Sponsor Name: NHS Lothian- University Hospitals Division
Full Title: A comparison of the efficacy of dietary hydroxypropylcellulose and questran as therapeutic agents in bile acid induced diarrhoea
Medical condition: these patients will have bile acid induced diarrhoea identified by an increased serum 7a-OH-cholestenone. and will have a history of one of 1. ileal resection 2. idiopathic bile acid diarrhoea.3. ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-001854-10 Sponsor Protocol Number: BO18039 Start Date: 2005-02-16
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: Randomized, two arm, placebo controlled double dummy study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in...
Medical condition: Metastatic Bone Pain
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-002453-31 Sponsor Protocol Number: AC-054-201 Start Date: 2005-02-15
Sponsor Name: Actelion Pharmaceuticals Ltd.
Full Title: A Phase IIb, multi-center, international, double-blind, randomized, placebo-controlled, parallel-group, dose-finding study for the prevention of cerebral vasospasm after aneurysmal subarachnoid hem...
Medical condition: Prevention of ischaemic complications related to vasospasm in patients with aneurysmal subarachnoid haemorrhage
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed)
Trial results: View results

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit